< Back to previous page
Researcher
Thomas Voets
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Physiology
- See also: Thomas Voets (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2012 → Today - Voets Lab (Research group)
Responsible
From1 Jul 2017 → Today - Laboratory of Ion Channel Research (VIB-KU Leuven) (Division)
Member
From1 Oct 2007 → Today - Faculty of Medicine (Faculty)
Member
From1 Oct 2002 → 30 Sep 2003
Projects
31 - 40 of 57
- Unraveling the role of TRMP3 in neuropathic and inflammatory pain.From1 Jan 2017 → 31 Dec 2019Funding: Foundations, funds and other with scientific goal, Other federal public and semi-governmental institutions
- TRPM3 as target for chemotherapy-induced peripheral neuropathic pain.From1 Jan 2017 → 31 Dec 2018Funding: Foundations, funds and other with scientific goal
- 3D-structure and function of a TRPM ion channelFrom1 Oct 2016 → 30 Sep 2019Funding: FWO fellowships
- The Curious Case of TRPV2: From Endometrial Cancer biomarker to Pharmacological TargetFrom1 Sep 2016 → 15 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- TRPM channel regulation by trafficking: mechanisms and physiological implicationsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- De rol van temperatuurgevoelige TRP-kanalen bij pijn en ontstekingFrom8 Sep 2015 → 3 Feb 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Microfluidics for single-cell omics. the C1 Single-Cell Auto Prep System, BioMark HD System and IFC controllers (Fluidigm) for single-cell analysesFrom19 May 2014 → 18 Nov 2018Funding: Hercules - Small and Medium size research infrastructure
- Unraveling molecular determinants of somatosensation via transcriptome analysis of single sensory neurons.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- TRP channels as pharmacological targets for lower urinary tract symptomsFrom1 Aug 2013 → 15 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Cellular regulation of transient receptor potential melastatin 3 (TRMP3) and its role in skin sensation.From1 Jun 2013 → 31 May 2015Funding: Marie Curie - People
Publications
1 - 10 of 231
- pH-dependent modulation of TRPV1 by modality-selective antagonists(2023)
Authors: Thomas Voets
Pages: 2750 - 2761 - β-Lactam TRPM8 Antagonists Derived from Phe-Phenylalaninol Conjugates: Structure-Activity Relationships and Antiallodynic Activity(2023)
Authors: Thomas Voets
- TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain(2023)
Authors: Davide Aloi, Thomas Voets, Joris Vriens
Pages: 2060 - 2069 - Primidone improves symptoms in TRPM3-linked developmental and epileptic encephalopathy with spike-and-wave activation in sleep(2023)
Authors: Evelien Van Hoeymissen, Thomas Voets, Joris Vriens
Pages: e61 - e68 - Protease secretions by the invading blastocyst induce calcium oscillations in endometrial epithelial cells via the protease-activated receptor 2(2023)
Authors: Katrien De Clercq, Karen Peeraer, Hugo Vankelecom, Thomas Voets, Joris Vriens
- Clotrimazole-Based Modulators of the TRPM3 Ion Channel Reveal Narrow Structure-Activity Relationship(2023)
Authors: Thomas Voets, Joris Vriens, Steven Verhelst
Pages: 456 - 464 - Gain- of- function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders(2023)
Authors: Evelien Van Hoeymissen, Katrien De Clercq, Thomas Voets, Joris Vriens
- Inhibition of TRPM8 by the urinary tract analgesic drug phenazopyridine.(2023)
Authors: Jan Daniluk, Annelies Janssens, Marie Mulier, Wouter Everaerts, Thomas Voets
- TRPM3 as novel target to alleviate acute oxaliplatin-induced peripheral neuropathy.(2022)
Authors: Davide Aloi, Joris Vriens, Thomas Voets
Number of pages: 10 - TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias(2022)
Authors: Andy Pironet, Sara Kerselaers, Joren Verelst, Wouter Oosterlinck, Bernd Nilius, Thomas Voets, Rudi Vennekens
Pages: 4195 - +
Patents
1 - 4 of 4
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Screening method for analgesic agents (Inventor)
- Treatment of pain (Inventor)